Press Room Contact Us Career Opportunities
  ABOUT LCM   INSTITUTIONAL SALES & TRADING   RESEARCH   PRIME SERVICES   EVENT CALENDAR  
         
        PRESS ROOM
  PRESS ROOM  
  PRESS ARCHIVE  
 
  FDA rejects Orexigen diet drug over heart risks
  February 1, 2011  
  Reuters  
 
 

An interview with Equity Research analyst William Tanner

Click here to view the article
 
             
    Business Continuity Plan   Terms and Conditions of Use   Member FINRA / SIPC